Roche has shared the numbers…
Roche has shared the numbers behind its phase 3 win [...]
Eli Lilly is heading back to its…
Eli Lilly is heading back to its regular Chinese collaborator [...]
On top of 348 known job cuts…
On top of 348 known job cuts across the organization [...]
Two dose-limiting toxicities have…
Two dose-limiting toxicities have been recorded in uniQure’s trial evaluating [...]
Belgian biotech Agomab…
Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass [...]
As Priovant works toward approval…
As Priovant works toward approval of potential blockbuster brepocitinib as [...]
Angitia Biopharmaceuticals has…
Angitia Biopharmaceuticals has unveiled its second mega-round in 14 months, [...]
Clinical-stage antibody company…
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull [...]
Quell Therapeutics is pressing…
Quell Therapeutics is pressing pause on an engineered regulatory T-cell [...]
Bayer has linked asundexian to a…
Bayer has linked asundexian to a 26% reduction in stroke [...]